Opportunistic HPV vaccination at age 16-23 and cervical screening attendance in Sweden: a national register-based cohort study

BMJ Open. 2018 Oct 2;8(10):e024477. doi: 10.1136/bmjopen-2018-024477.

Abstract

Objectives: To investigate whether cervical screening attendance differs between human papillomavirus (HPV)-vaccinated and unvaccinated women and to investigate potential underlying socioeconomic factors.

Design: Prospective cohort using registry linkage of vaccinations, screening invitations, screening attendance and socioeconomic covariates.

Setting: Swedish national HPV vaccination and cervical screening programmes.

Participants: All Swedish women born between 1988 and 1991 and invited to screening (n=261 434).

Outcome measures: All participants were followed for up to 3 years. Screening attendance was compared between HPV-vaccinated and unvaccinated women. HR and 95% CI were estimated using Cox regression.

Results: Vaccination age averaged 18.1 years and the coverage for≥1 dose was 13.5%. In HPV-vaccinated women (n=35 460), screening attendance was higher than in unvaccinated women (n=225 974) (74%vs69%, p<0.001). The crude HR of attendance in HPV-vaccinated women was 1.32 (95% CI 1.30 to 1.34). A positive association remained after adjustment for education, income and migration history (HR=1.10, 95% CI 1.09 to 1.12).

Conclusion: HPV-vaccinated women were more likely to attend screening than unvaccinated women. Yet, the question needs to be reassessed in routinely vaccinated cohorts, since the vaccinated women included here represent a selected group and may be prone to more health-conscious habits.

Keywords: HPV; Sweden; cervical screening; screening attendance; vaccination.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Female
  • Humans
  • Mass Screening / statistics & numerical data*
  • Papillomavirus Infections / diagnosis*
  • Papillomavirus Infections / prevention & control
  • Papillomavirus Vaccines / therapeutic use*
  • Patient Participation*
  • Prospective Studies
  • Registries
  • Sweden / epidemiology
  • Uterine Cervical Neoplasms / prevention & control
  • Uterine Cervical Neoplasms / virology*
  • Vaccination / statistics & numerical data*
  • Young Adult

Substances

  • Papillomavirus Vaccines